Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.94
Delayed Data
As of Dec 14
 -0.02 / -1.02%
Today’s Change
1.27
Today|||52-Week Range
7.10
+36.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization8.8K8.9K11.0K11.0K
 
 
 
 
 
 
Operating ExpensesGross Income-8.8K-8.9K-11.0K-11.0K
 
 
 
 
 
General Expenses3.9M3.9M4.3M4.2M
 
 
 
 
 
Research And Development2.1M2.3M2.5M2.6M
 
 
 
 
 
Total Operating Expenses3.9M4.0M4.3M4.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-4.0M-4.3M-4.2M
 
 
 
 
 
Extraordinary Credit3.4M0.005.5M3.1M
 
 
 
 
Extraordinary Charge0.00-17.7M0.000.00
 
 
Other Expenses0.000.00-333.1K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-525.5K-21.6M947.1K-1.0M
 
 
 
 
 
Net Income-525.5K-21.6M947.1K-1.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.7M23.9M26.0M28.5M
 
 
 
 
 
Shares To Calculate EPS Diluted23.7M23.9M28.3M28.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00-$0.90$0.03-$0.04
 
 
 
 
EPS Diluted-$0.02-$0.90$0.03-$0.04